Coin2Dose for Type 1 Diabetes

Children's Mercy Kansas City, Kansas City, MO
Type 1 DiabetesCoin2Dose - Behavioral
Eligibility
11 - 17
All Sexes
What conditions do you have?
Select

Study Summary

This trial aims to see if incentives can help teens with diabetes use insulin better, using semi-automated tech.

Eligible Conditions
  • Type 1 Diabetes

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
Outpatient therapy: 8 weeks of drug therapy with usual treatment + 5 weeks of closed-loop therapy
1
Semaglutide
1
Semaglutide

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: change in week 0 outcome at week 13

Week 13
Change in Glucose time in range
Change in Glycated Hemoglobin- HbA1c
Change in daily insulin Bolus score

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

2
Outpatient therapy: 8 weeks of drug therapy with usual treatment + 5 weeks of closed-loop therapy
2
Semaglutide
2
Semaglutide

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Standard Care Control
1 of 2
Coin2Dose
1 of 2

Active Control

Experimental Treatment

150 Total Participants · 2 Treatment Groups

Primary Treatment: Coin2Dose · No Placebo Group · N/A

Coin2Dose
Behavioral
Experimental Group · 1 Intervention: Coin2Dose · Intervention Types: Behavioral
Standard Care ControlNoIntervention Group · 1 Intervention: Standard Care Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: change in week 0 outcome at week 13

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor
115 Previous Clinical Trials
16,605 Total Patients Enrolled

Eligibility Criteria

Age 11 - 17 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a teenager with type 1 diabetes who uses an insulin pump to manage your condition.
References

Frequently Asked Questions

Does this research endeavor allow participants aged 18 and over?

"The criteria for being a part of this clinical trial states that the participant must be aged between 11 and 17." - Anonymous Online Contributor

Unverified Answer

Is it possible to register for this study at the current time?

"This clinical trial is still accepting participants. It was first listed on the 1st of January 2023 and last amended on 28th February 2023 per information provided by clinicaltrials.gov." - Anonymous Online Contributor

Unverified Answer

Am I eligible to participate in this scientific investigation?

"This trial is on the search for 150 juvenile individuals with type 1 diabetes, aged between 11 and 17 years. To be eligible to participate, adolescents must have a doctor-verified diagnosis of T1D lasting at least 6 months; they should use insulin pumps to manage their condition; and they need to demonstrate suboptimal daily BOLUS scores (a mean score lower than 2.5)." - Anonymous Online Contributor

Unverified Answer

How many participants are currently involved in this research endeavor?

"Affirmative. The info hosted on clinicaltrials.gov reveals that this research, which was initially advertised on January 1st 2023, is still actively recruiting participants. 150 people are required to be enrolled from 2 medical centres." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top